MAA
LOXO

Managed Account Advisors’s Loxo Oncology, Inc LOXO Stock Holding History

Managed Account Advisors’s Portfolio LOXO Stock Details LOXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		$11K Buy
601
+3
+0.5% +$41 ﹤0.01% 2874
2015
Q1 		$7K Sell
598
-7
-1% -$87 ﹤0.01% 2858
2014
Q4 		$7K Sell
605
-69
-10% -$804 ﹤0.01% 2649
2014
Q3 		$9K Buy
+674
New +$8.74K ﹤0.01% 2612

Other funds holding LOXO

AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Axa
Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return

Managed Account Advisors's LOXO Position: Q2 2015 in Review

Managed Account Advisors increased its Loxo Oncology, Inc (LOXO) stake by 0.5% in Q2 2015, buying an estimated $41 and bringing the position to 601 shares worth $11K. The position accounts for ﹤0.01% of the portfolio, ranked #2874.

Managed Account Advisors first reported a position in LOXO in Q3 2014 and has held it in 4 quarters since. 50 funds tracked by Wall St. Rank hold LOXO as of Q2 2015.

  • Managed Account Advisors held 601 shares of Loxo Oncology, Inc worth $11K as of Q2 2015.
  • Managed Account Advisors bought 3 Loxo Oncology, Inc shares in Q2 2015, an estimated $41.
  • Loxo Oncology, Inc made up ﹤0.01% of Managed Account Advisors's portfolio in Q2 2015, its #2874 holding.
  • Managed Account Advisors first reported a position in Loxo Oncology, Inc in Q3 2014 and has held it in 4 quarters since.
  • 50 funds tracked by Wall St. Rank held Loxo Oncology, Inc as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.